| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Formela Jean Francois is a Director at SPRO with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 47 sells.
Estimated insider holdings value: $15.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | KRRO Korro Bio, Inc. | Director | Sell | 171,405 | $14.34 | $2,458,582.35 | -4.0% | - | - | |
| May 28, 2026 | KRRO Korro Bio, Inc. | Director | Sell | 2,860 | $13.95 | $39,897.00 | -0.3% | - | - | |
| Dec 14, 2021 | IMA Imagenebio, Inc. | Director | Sell | 26,278 | $14.67 | $385,571.87 | -0.7% | -59.2% | -80.1% | |
| Jun 28, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 553,376 | $132.73 | $73,448,878.91 | -13.8% | +10.6% | -61.0% | |
| Jun 14, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 201,725 | $87.04 | $17,558,773.95 | -4.2% | +75.4% | -56.3% | |
| Apr 29, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 4,513 | $85.43 | $385,545.59 | -0.6% | +70.0% | -38.8% | |
| Apr 28, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 342,962 | $85.96 | $29,482,338.40 | -5.8% | +55.2% | -41.1% | |
| Apr 5, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 800 | $84.98 | $67,984.00 | - | +86.3% | -12.6% | |
| Mar 30, 2021 | IMA Imagenebio, Inc. | Director | Buy | 125,000 | $16.00 | $2,000,000.00 | +16.7% | -44.1% | -76.1% | |
| Feb 26, 2021 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 501,945 | $60.29 | $30,262,715.80 | -31.1% | - | - |